224 related articles for article (PubMed ID: 37139492)
1. Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells.
Mamana J; Humber GM; Espinal ER; Seo S; Vollmuth N; Sin J; Kim BJ
Front Cell Infect Microbiol; 2023; 13():1171275. PubMed ID: 37139492
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
3. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
J Virol; 2021 May; 95(12):. PubMed ID: 33827951
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers.
Robinson SM; Tsueng G; Sin J; Mangale V; Rahawi S; McIntyre LL; Williams W; Kha N; Cruz C; Hancock BM; Nguyen DP; Sayen MR; Hilton BJ; Doran KS; Segall AM; Wolkowicz R; Cornell CT; Whitton JL; Gottlieb RA; Feuer R
PLoS Pathog; 2014 Apr; 10(4):e1004045. PubMed ID: 24722773
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell
Kraft L; Sauter M; Seebohm G; Klingel K
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416
[TBL] [Abstract][Full Text] [Related]
6. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections.
Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL
mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620
[TBL] [Abstract][Full Text] [Related]
7. Direct and Indirect Effects on Viral Translation and RNA Replication Are Required for AUF1 Restriction of Enterovirus Infections in Human Cells.
Ullmer W; Semler BL
mBio; 2018 Sep; 9(5):. PubMed ID: 30181254
[TBL] [Abstract][Full Text] [Related]
8. Role of RNA Domain Structure and Orientation in the Coxsackievirus B3 Virulence Phenotype.
Phillips L; Tapprich WE
J Virol; 2023 May; 97(5):e0044823. PubMed ID: 37074194
[TBL] [Abstract][Full Text] [Related]
9. Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.
Kühnl A; Rien C; Spengler K; Kryeziu N; Sauerbrei A; Heller R; Henke A
Med Microbiol Immunol; 2014 Aug; 203(4):217-29. PubMed ID: 24615265
[TBL] [Abstract][Full Text] [Related]
10. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.
Sharma A; Marceau C; Hamaguchi R; Burridge PW; Rajarajan K; Churko JM; Wu H; Sallam KI; Matsa E; Sturzu AC; Che Y; Ebert A; Diecke S; Liang P; Red-Horse K; Carette JE; Wu SM; Wu JC
Circ Res; 2014 Aug; 115(6):556-66. PubMed ID: 25015077
[TBL] [Abstract][Full Text] [Related]
11. Human astrocytic cells support persistent coxsackievirus B3 infection.
Zhang X; Zheng Z; Shu B; Liu X; Zhang Z; Liu Y; Bai B; Hu Q; Mao P; Wang H
J Virol; 2013 Nov; 87(22):12407-21. PubMed ID: 24027313
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.
Rani P; George B; V S; Biswas S; V M; Pal A; Rajmani RS; Das S
J Virol; 2024 Feb; 98(2):e0150423. PubMed ID: 38289119
[TBL] [Abstract][Full Text] [Related]
13. Persistent Coxsackievirus B3 Infection in Pancreatic Ductal Cells
Mastrodomenico V; LoMascolo NJ; Firpo MR; Villanueva Guzman MDM; Zaporowski A; Mounce BC
mSphere; 2023 Jun; 8(3):e0003623. PubMed ID: 37097178
[TBL] [Abstract][Full Text] [Related]
14. Testosterone Promotes the Intestinal Replication and Dissemination of Coxsackievirus B3 in an Oral Inoculation Mouse Model.
Dhalech AH; Corn CM; Mangale V; Syed F; Condotta SA; Richer MJ; Robinson CM
J Virol; 2022 Sep; 96(17):e0123222. PubMed ID: 36037480
[TBL] [Abstract][Full Text] [Related]
15. Expression Profile and Function Analysis of Long Non-coding RNAs in the Infection of Coxsackievirus B3.
Tong L; Qiu Y; Wang H; Qu Y; Zhao Y; Lin L; Wang Y; Xu W; Zhao W; He H; Zhao G; Zhang MH; Yang D; Ge X; Zhong Z
Virol Sin; 2019 Dec; 34(6):618-630. PubMed ID: 31388922
[TBL] [Abstract][Full Text] [Related]
16. CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway.
Wang L; Xie W; Zhang L; Li D; Yu H; Xiong J; Peng J; Qiu J; Sheng H; He X; Zhang K
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258014
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
18. The role of autophagy during coxsackievirus infection of neural progenitor and stem cells.
Tabor-Godwin JM; Tsueng G; Sayen MR; Gottlieb RA; Feuer R
Autophagy; 2012 Jun; 8(6):938-53. PubMed ID: 22751470
[TBL] [Abstract][Full Text] [Related]
19. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
20. The Nuclear Pore Complex 62 Suppression Inhibits Coxsackievirus B Replication and Inflammatory Response.
Liu T; Shi Y; Wang H; Shen H; Qu J
Viral Immunol; 2022 Jun; 35(5):381-385. PubMed ID: 35605096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
